[1] ALLARD S,CORT J,HOWELL C,et al.Transfusion 20 24:a 5-year plan for clinical and laboratory transfusion in England[J].Transfus Med,2021,31(6):400-408.
[2] WALL J,DHESI J,SNOWDEN C,et al.Perioperative medicine[J]. Future Healthc J,2022,9(2):138-143.
[3] IACOBUCCI G.NHSX:Hancock sets up new policy unit to support technology in NHS[J]. BMJ,2019,364:l793.
[4] CARSON J L,STANWORTH S J,ROUBINIAN N,et al.Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion[J]. Cochrane Database Syst Rev,2016,10(10):CD002042.
[5] CARSON J L,TERRIN M L,NOVECK H,et al.Liberal or restrictive transfusion in high-risk patients after hip surgery[J]. N Engl J Med,2011,365(26):2453-2462.
[6] MURPHY M F,PALMER A.Patient blood management as the standard of care[J].Hematology Am Soc Hematol Educ Program,2019,2019(1):583-589.
[7] CURLEY A,STANWORTH S J,WILLOUGHBY K,et al.Randomized trial of platelet-transfusion thresholds in neonates[J]. N Engl J Med,2019,380(3):242-251.
[8] LACROIX J,HÉBERT P C,HUTCHISON J S,et al.Transfusion strategies for patients in pediatric intensive care units[J].N Engl J Med,2007,356(16):1609-1619.
[9] STANWORTH S J,ESTCOURT L J,POWTER G,et al.A no-prophylaxis platelet-transfusion strategy for hematologic cancers[J].N Engl J Med,2013,368(19):1771-1780.
[10] 樊凤艳,汪德清.我国临床输血发展的挑战与思考[J]. 临床输血与检验,2021,23(1):10-12.
[11] 王小万,陈丽萍,刘丽杭.英国国民卫生服务制度(NHS)的结构性改革与治理模式[J].中国卫生政策研究,2017,10(11):27-35.
[12] Patient Blood Management.Accessed August 10, 2022.https://www.aabb.org/news-resources/resources/patient-blood-management.
[13] WHO.Action framework to advance universal access to safe, effective and quality-assured blood products2020-2023 [EB/OL]. (2022-08-16).https://www.who.int/publications/i/item/9789240000384.
[14] SHERLIKER L,PENDRY K,HOCKLEY B.Patient blood management:how is implementation going? :a report comparing the 2015 survey with the 2013 survey of PBM in England[J].Transfus Med,2018,28(2):92-97.
[15] 国家卫生健康委员会.围手术期患者血液管理指南:WS/T 796—2022[S]. 北京:中国标准出版社,2022.
[16] 中国输血协会临床输血学专业委员会,外科ICU患者血液管理专家共识(2021版)编审委员会.外科ICU患者血液管理专家共识(2021版)[J].中华危重症医学杂志(电子版),2021,14(4):265-268.
[17] 中国输血协会临床输血学专业委员会.内科重症监护病房的患者血液管理专家共识[J].临床血液学杂志,2020,33(2):83-86.
[18] 北京医学会输血医学分会,北京医师协会输血专业专家委员会. 中国输血医师规范化培训实施方案专家共识[J]. 临床输血与检验,2021,23(1):1-5.
[19] BOLTON-MAGGS P H B.Serious hazards of transfusion-conference report:celebration of 20 years of UK haemovigilance[J].Transfus Med,2017,27(6):393-400.
[20] SHOT.Headline Data: Deaths, Major Morbidity and ABO-Incompatible Transfusions. Accessed September 5, 2022[EB/OL]. https://www.shotuk.org/shot-reports/report-summary-and-supplement-2021/2021-annual-shot-report-individual-chapters/.
[21] 陈莉,贾桂丛,戚海,等. 某省血液安全监测平台构建研究[J]. 中国卫生质量管理,2018,25(6):1-4.
[22] 郝欣欣,王秋实,王玉婷,等.辽宁地区2019年临床输血不良反应调查分析[J].中国输血杂志,2020,33(8):809-813.
[23] 中国输血协会.血液安全监测指南[S].[EB/OL](2019-04-23).http://www.ttbz.org.cn/Home/Show/7285/.
[24] 胡伟,孔长虹.我国血液信息化建设:现状与展望[J].临床输血与检验,2021,23(6):711-714.
[25] 沈鑫,杨江存,徐翠香,等.基于人工智能的输血决策支持系统构建和实施[J].中国卫生信息管理杂志,2021,18(4):455-459.
[26] 车辑,刘景汉,李卉,等.通用O型全血的初步研究[J]. 临床输血与检验,2008,10(1):1-4.
[27] 王淑英,周武,汪德清.中国汉族人群通用血浆制备方法研究[J]. 实用检验医师杂志,2011,3(1):9-12.
[28] 杨江存,高英,孙杨,等.4℃冷藏保存血小板功能变化[J].中国输血杂志,2017,30(6):553-557.
[29] 贺敏威,孙苏静,周欠欠,等. 2020年度输血医学科研新进展[J].临床输血与检验,2021,23(1):13-16. |
